Integrity Biochem HSC 70-VA
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
14,806 recalls, newest first
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Failed Excipient Specifications: high content of ethylene glycol (EG)
Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.
CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.
Labeling: Not Elsewhere Classified
Labeling: Not Elsewhere Classified
Labeling: Not Elsewhere Classified
Failed Dissolution Specifications
Subpotent: Failing Test Results for Epinephrine
Presence of Particulate Matter: identified as glass.
Presence of Particulate Matter: identified as glass.
Presence of Particulate Matter: identified as glass.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility